相关实验视频

Updated: Aug 7, 2026

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats

Published on: October 16, 2010

基于计算机断层扫描的SBMA的放射性妇科马斯蒂亚作为一个独立的差异诊断生物标志物:一个回顾性研究

Minsung Kang¹, Byoung Je Kim², Brian Nguyen³

¹Department of Neurology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Hoguk-ro 807, Buk-gu, Daegu, Republic of Korea.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

|October 29, 2024

概括

胸部CT扫描显示,脊柱囊筋肌缩症 (SBMA) 患者与肌缩性侧面硬化症 (ALS) 患者相比,乳腺组织的显著差异. 在CT成像上的放射性性妇可以帮助区分早期的SBMA和ALS.

科学领域:

神经学神经学
放射学放射学是一门学科.
医疗成像医学成像

背景情况:

脊柱囊筋肌缩 (SBMA) 和肌缩侧面硬化症 (ALS) 是运动神经元疾病,具有重叠的早期临床症状.
在早期阶段区分SBMA和ALS可能是具有挑战性的,因为表现类似.

研究的目的:

评估胸部计算机断层扫描 (CT) 图像在区分SBMA和ALS中的有效性.
为了研究放射性妇科马斯蒂亚作为SBMA的诊断标记物的实用性.

主要方法:

对SBMA,ALS和对照患者的胸部CT图像进行了回顾性分析.
测量乳腺腺组织直径和评估CT扫描的形态学.
在SBMA组中,CT测量三组之间的妇联的比较和与临床参数的相关性.

主要成果:

与ALS (15.91 mm) 和对照组 (15.76 mm) 相比,SBMA患者的胸部CT显示了显著更大的平均腺组织直径 (32.22 mm).
在SBMA中,放射性性妇联非常普遍 (93.3%),具有明显的扩散腺体形态模式 (50%).
在SBMA和ALS组之间,BMI,功能尺度或年龄没有显著差异.

结论:

基于CT的辐射性妇产的评估有效地区分了SBMA和ALS.
通过胸部CT识别的放射性妇科马斯作为SBMA的有价值的差异诊断标志物,特别是在早期疾病阶段.

关键词:

计算机断层扫描 (CT) 是一种计算机断层扫描.诊断诊断诊断诊断诊断不同的差异是不同的.妇产科马斯蒂亚妇产科马斯蒂亚脊柱泡状肌肉缩脊柱泡状肌肉缩

更多相关视频

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Published on: December 15, 2014

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos

Published on: March 21, 2021

相关概念视频

Rapid Identification of Pathogens

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...